# US 6,730,678 B2 · Benzoylguanidine salt and hydrates thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,678 B2
- Document ID: US6730678B2
- Status: Granted
- Kind: B2
- Application number: 10/057,597
- Filed: 2002-01-25
- Published: 2002-09-26
- Granted: 2004-05-04
- Earliest claimed: 2001-02-15
- Assignees: Boehringer Ingelheim Pharma GmbH & Co. KG
- Inventors: Christian Eickmeier; Peter Sieger; Werner Rall; Volkmar Koerner; Rolf Herter
- Web page: https://patentgrep.com/patent/US6730678B2

## CPC

- C07D 403/02: containing two hetero rings
- C07D 207/34: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D 207/416: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

4-[4-(2-pyrrolylcarbonyl)-1-piperazinyl]-3-trifluoromethylbenzoylguanidine hydrochloride and its hydrates, processes for preparing this benzoylguanidine salt and its hydrates, pharmaceutical compositions containing this benzoylguanidine salt and its hydrates, and its use in treating diseases, particularly those in which inhibition of the cellular Na+/H+ exchange is of therapeutic benefit.

## Claims

### Claim 1

A hydrate of 4-[4-(2-pyrrolylcarbonyl)-1-piperazinyl]-3-trifluoromethylbenzoylguanidine hydrochloride 1

### Claim 2

A monohydrate of 4-[4-(2-pyrrolylcarbonyl-1-piperazinyl]-3-trifluoromethylbenzoylguanidine hydrochloride 1

### Claim 3

A hemihydrate of 4-[4-(2-pyrrolylcarbonyl)-1-piperazinyl]-3-trifluoromethylbenzoylguanidine hydrochloride 1

### Claim 4 (depends on 1)

A pharmaceutical composition comprising:
(a) the compound according to claim 1; and
(b) a pharmaceutically acceptable excipient.

### Claim 5 (depends on 2)

A pharmaceutical composition comprising:
(a) the compound according to claim 2; and
(b) a pharmaceutically acceptable excipient.

### Claim 6 (depends on 3)

A pharmaceutical composition comprising:
(a) the compound according to claim 3; and
(b) a pharmaceutically acceptable excipient.
